Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer

Mostrar otras versiones (1)

Currently, gastric cancer is the third most common cause of cancer-associated mortality worldwide. Oncolytic virotherapy using herpes simplex virus (HSV) has emerged as a novel therapeutic strategy against cancer. Telomerase is activated in >90of malignant tumors, including gastric cancer, and hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Tomoya, Nakamori, Mikihito, Matsumura, Shuichi, Nakamura, Masaki, Ojima, Toshiyasu, Fukuhara, Hiroshi, Ino, Yasushi, Todo, Tomoki, Yamaue, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100961/
https://www.ncbi.nlm.nih.gov/pubmed/33968206
http://dx.doi.org/10.3892/ol.2021.12751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100961/
https://www.ncbi.nlm.nih.gov/pubmed/33968206
http://dx.doi.org/10.3892/ol.2021.12751

Ejemplares similares